Results
20
Large pharmaceutical stocks to buy with strong dividend features.
20 companies
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
CIPLA | ₹1,454.10 | -3.1% | 19.5% | ₹1.2t | ₹1,629.72 | PE26.2x | E7.3% | 0.9% | ||
500488 | ₹28,865.15 | 0.09% | 26.7% | ₹613.4b | ₹28,117.14 | PE47.7x | E11.0% | 1.4% | ||
AJANTPHARM | ₹2,793.70 | -6.6% | 46.9% | ₹348.9b | ₹2,973.91 | PE39.9x | E16.4% | 2.0% | ||
500124 | ₹1,238.45 | 1.9% | 10.7% | ₹1.0t | ₹1,336.87 | PE19.3x | E-1.0% | 0.6% | ||
SUNPHARMA | ₹1,814.00 | 0.8% | 47.1% | ₹4.4t | ₹2,047.11 | PE39.4x | E12.7% | 0.7% | ||
506943 | ₹1,813.35 | 0.2% | 24.9% | ₹281.6b | ₹2,173.77 | PE46.1x | E19.4% | 0.7% | ||
500257 | ₹2,149.40 | 2.3% | 71.6% | ₹980.6b | ₹2,218.36 | PE37.3x | E16.4% | 0.4% | ||
ZYDUSLIFE | ₹986.45 | 1.7% | 53.6% | ₹992.6b | ₹1,083.36 | PE23.2x | E0.7% | 0.3% | ||
IPCALAB | ₹1,552.20 | 4.3% | 41.2% | ₹393.8b | ₹1,564.37 | PE59.6x | E30.1% | 0.3% | ||
500660 | ₹2,345.45 | -2.3% | 35.2% | ₹397.3b | ₹2,914.50 | PE58.9x | E16.8% | 1.4% | ||
GLAND | ₹1,775.30 | -1.4% | -1.6% | ₹292.5b | ₹1,813.25 | PE42.3x | E25.8% | 1.1% | ||
PFIZER | ₹5,076.30 | -5.3% | 23.9% | ₹232.2b | ₹5,935.00 | PE37.6x | E12.9% | 0.7% | ||
500420 | ₹3,374.30 | 0.7% | 62.2% | ₹1.1t | ₹3,591.55 | PE63.4x | E22.6% | 0.8% | ||
524742 New | ₹2,467.90 | 5.0% | 102.3% | ₹187.6b | ₹2,396.67 | PE38x | E13.6% | 0.2% | ||
NATCOPHARM | ₹1,462.55 | 2.2% | 92.7% | ₹262.0b | ₹1,343.09 | PE13.5x | E-20.4% | 0.4% | ||
ALKEM | ₹5,489.95 | -3.2% | 12.4% | ₹656.4b | ₹5,775.29 | PE30.9x | E10.6% | 0.7% | ||
CONCORDBIO | ₹2,194.70 | 0.6% | 66.0% | ₹229.6b | ₹2,041.25 | PE70x | E26.9% | 0.4% | ||
AUROPHARMA New | ₹1,225.85 | -2.7% | 18.3% | ₹712.0b | ₹1,537.14 | PE19.9x | E13.9% | 0.2% | ||
530019 | ₹1,149.00 | -6.2% | 151.4% | ₹181.9b | ₹1,259.00 | PE30.7x | E5.5% | 0.4% | ||
APLLTD | ₹1,091.95 | -0.2% | 44.6% | ₹214.6b | ₹1,161.92 | PE33.2x | E21.5% | 1.0% |